We encourage women and families who have suffered from Yaz and stroke side effects while using Yaz contraception and to report their problems to the Food and Drug Administration (FDA).

Report Your Yaz Stroke Problem: FDA MedWatch

Yasmin and Yaz FDA Medication Warnings Letters

The manufacturer of Yaz and Yasmin have come under inquiry due to their advertising and marketing practices of these birth control pills. In July 2003 the FDA sent a warning letter to Berlex Laboratories for broadcasting misleading television commercials for Yasmin. The FDA notified the company that they were airing misleading advertisements concluding, “In summary, the TV ad not only misleads consumers about the efficacy of Yasmin, the ad also minimizes important context about the health risks of the drug.”

Again in 2008, the FDA issued a warning letter to the healthcare corporation Bayer who was the current manufacturer of Yaz regarding another misleading advertisement. The Food and Drug Administration outlined in their letter to Bayer, “These violations are concerning from a public health perspective because they encourage use of YAZ in circumstances other than those in which the drug has been approved, over-promise the benefits and minimize the risks associated with YAZ.”

The following sections are from a Yaz warning label regarding Yaz stroke risks.

Cerebrovascular diseases

Oral contraceptives have been shown to increase both the relative and attributable risks of cerebrovascular events (thrombotic and hemorrhagic strokes), although, in general, the risk is greatest among older (>35 years), hypertensive women who also smoke. Hypertension was found to be a risk factor, for both users and nonusers, for both types of strokes, while smoking interacted to increase the risk for hemorrhagic strokes.

In a large study, the relative risk of thrombotic strokes has been shown to range from 3 for normotensive users to 14 for users with severe hypertension. The relative risk of hemorrhagic stroke is reported to be 1.2 for nonsmokers who used oral contraceptives, 2.6 for smokers who did not use oral contraceptives, 7.6 for smokers who used oral contraceptives, 1.8 for normotensive users and 25.7 for users with severe hypertension. The attributable risk is also greater in older women. Oral contraceptives also increase the risk for stroke in women with other underlying risk factors such as certain inherited or acquired thrombophilias, hyperlipidemias, and obesity. Women with migraine (particularly migraine with aura) who take combination oral contraceptives may be at an increased risk of stroke.

HEART ATTACKS AND STROKES

Oral contraceptives may increase the tendency to develop strokes (stoppage or rupture of blood vessels in the brain) and angina pectoris and heart attacks (blockage of blood vessels in the heart). Any of these conditions can cause death or serious disability.

Smoking greatly increases the possibility of suffering heart attacks and strokes. Furthermore, smoking and the use of oral contraceptives greatly increases the chances of developing and dying of heart disease.

We represent all women suffering from Yaz and stroke side effects including working with families of a loved one who died from complications caused by Yaz on a contingency basis which means that there are never any legal fees unless we win compensation in your case. For a free no-obligation case review please call toll free at 1-888-343-5375 or fill out our short online contact form and a Yaz stroke attorney will contact you to answer any of your questions.